AGN vs BOT: Side-by-Side Comparison
Compare Argenica Therapeutics Ltd (AGN) and Botanix Pharmaceuticals Ltd (BOT) side by side: market cap AUD 15.41M vs AUD 57.42M. Financials, growth and model signals on Bullrun.
| Metric | AGN | BOT |
|---|---|---|
| Company | Argenica Therapeutics Ltd | Botanix Pharmaceuticals Ltd |
| Country / Exchange | Australia · AU | Australia · AU |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | AUD 15.41M | AUD 57.42M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | — | AUD 5.76M |
| Revenue growth YoY | — | +856.6% |
| Net income | AUD -7.17M | AUD -86.40M |
| Gross margin | — | 40.3% |
| Diluted EPS | -0.06 | -0.05 |